Joshua E. Kolanko, FNP-C

Joshua Kolanko practices at Tampa General Hospital Crystal River in Crystal River, Florida, part of Tampa General Hospital.

Joshua Kolanko's NPI, 1821086745, was assigned on October 13, 2005. Joshua Kolanko holds Florida license ARPR9328710.

Joshua Kolanko's primary practice is Tampa General Hospital Crystal River, at 6201 N Suncoast Blvd, Crystal River, FL 34428 in Citrus County. The practice phone is (352) 795-6560.

Joshua Kolanko's primary practice is Tampa General Hospital Crystal River in Crystal River, Florida, part of Tampa General Hospital. The medical group on file is Paragon Emergency Services LLC. Dmand AI also links Joshua Kolanko to 6 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joshua Kolanko practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Joshua Kolanko's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Joshua Kolanko's licenses on file in 2 states: Florida and West Virginia.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, asthma, bronchitis, bursitis, chronic nasal allergies and conjunctivitis among the conditions Joshua Kolanko treats.

CMS data shows 105 Medicare services from Joshua Kolanko across 3 procedure codes in 2024, for 81 Medicare patients. Medicare paid $6,105 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 81 Medicare patients who saw Joshua Kolanko in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Joshua Kolanko's median patient age at 80, with 66% women.

In 2024, Joshua Kolanko wrote 211 Medicare Part D claims for 101 patients. 88% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $410 in total drug cost.